ERS International Congress, Madrid 2019

Browse by day: Saturday, 28.09.2019 Sunday, 29.09.2019 Monday, 30.09.2019 Tuesday, 01.10.2019 Wednesday, 02.10.2019		View the presentations you missed during Congress! More than 1,000 webcasts and slide presentations, 1,900 e-posters and 4,200 abstracts from the International Congress in Madrid and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2019; 54: Suppl. 63, abstract number.

Tuberculosis and non-TB mycobacterial infection II

Thematic Poster
Chairs: D. Wagner (Freiburg, Germany), M. Jankovic Makek (Zagreb, Croatia), H. Kunst (London, United Kingdom), S. Borisov (Moscow, Russian Federation)

Download all media

Clinical features of XDR-TB patients L. Rusakova (Moscow, Russian Federation), S. Sterlikov (Moscow, Russian Federation), V. Galkin (St-Petersburg, Russian Federation)
Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience T. Han Loong (Kuala Lumpur, Malaysia), S. Shahul Hamid (Kuala Lumpur, Malaysia), S. Sirol Aflah (Kuala Lumpur, Malaysia), N. Muhammad (Kuala Lumpur, Malaysia), Z. Abu Bakar (Kuala Lumpur, Malaysia), N. Mohd Marzuki (Kuala Lumpur, Malaysia)
Socio-demographic factors and drug resistance of M. tuberculosis in patients registered in megapolis A. Chizhova (Moscow, Russian Federation), S. Safonova (Moscow, Russian Federation), Y. Mikhajlova (Moscow, Russian Federation), M. Krasnova (Moscow, Russian Federation), A. Khakhalina (Moscow, Russian Federation), I. Peretokina (Moscow, Russian Federation), E. Belilovsky (Moscow, Russian Federation)
Effect of additional drug resistance of M tuberculosis in patients with Hr-TB on the efficacy of chemotherapy A. Samoilova (Moscow, Russian Federation), I. Burmistrova (Moscow, Russian Federation), K. Glebov (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), T. Radina (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia R. Curcic (Belgrade, Republic of Serbia), D. Vukovic (Belgrade, Republic of Serbia), I. Zivanovic (Belgrade, Republic of Serbia), I. Dakic (Belgrade, Republic of Serbia), B. Savic (Belgrade, Republic of Serbia)
Disseminated nontuberculous pulmonary mycobacteriosis in patients at late stages of HIV infection V. Romanov (Moscow, Russian Federation), V. Mishin (Moscow, Russian Federation), A. Mishina (Moscow, Russian Federation), A. Sobkin (Moscow, Russian Federation)
Efficacy and safety of levamisole as an immunomodulator in the treatment of drug resistant tuberculosis N. SARANGDHAR (MUM, India), K. Mohanty (MUM, India)
Frequent adverse events during prolonged Bedaquiline treatment on XDR-tuberculosis patients A. Tikhonov (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), M. Burakova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation)
To search for optimal tactics for MDR cavitary tuberculosis A. Bazhenov (Ekaterinburg, Russian Federation), I. Motus (Ekaterinburg, Russian Federation), E. Kildyusheva (Ekaterinburg, Russian Federation), I. Medvinsky (Ekaterinburg, Russian Federation), S. Skornyakov (Ekaterinburg, Russian Federation), D. Vakhrusheva (Ekaterinburg, Russian Federation)
The use of totally implantable central venous access ports for the treatment of multidrug-resistant tuberculosis (MDR-TB) at the programmatic level. Prospective cohort study A. Skrahin (Minsk, Belarus), D. Pechinski (Minsk, Belarus), M. Makouski (Minsk, Belarus), H. Hurevich (Minsk, Belarus), A. Sinha (Minsk, Belarus), S. Aliushin (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahina (Minsk, Belarus)
The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis E. Zhukova (Novosibirsk, Russian Federation), E. Myshkova (Novosibirsk, Russian Federation)
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India. R. Takhar (KOTA, India), A. Saxena (KOTA, India), S. Khangarot (KOTA, India), R. Garg (KOTA, India), B. Bansiwal (KOTA, India), K. Shringi (KOTA, India)
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients G. Kaminskiy (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), V. Zimina (Moscow, Russian Federation), A. Peregudova (Moscow, Russian Federation), O. Kudrja (Moscow, Russian Federation), E. Beloborodova (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
Clinical effect of combined chemotherapy according to guidelines fro the treatment of pulmonary Mtcobacterium complex disease, including a follow-up study. Y. Kobashi (Kurashiki, Japan), M. Abe (Kurashiki, Japan), R. Shirai (Kurashiki, Japan), S. Kato (Kurashiki, Japan), T. Oga (Kurashiki, Japan)
Remarkable diversity in the geographic distribution of NTM species in Bursa, Turkey: Analysis of nontuberculous mycobacterial pulmonary disease in a two years retrospective cohort A. Dilektasli (BURSA, Turkey), G. Turkan (BURSA, Turkey), E. Demirdogen (BURSA, Turkey), T. Bulut (BURSA, Turkey), A. Ursavas (BURSA, Turkey), F. Coskun (BURSA, Turkey), C. Özakin (BURSA, Turkey), H. Akalin (BURSA, Turkey), M. Karadag (BURSA, Turkey)
Identification of nontuberculous mycobacteria (NTM) isolated from patients from the TB hospital N. Eremeeva (Yekaterinburg, Russian Federation), K. Belousova (Yekaterinburg, Russian Federation), T. Umpeleva (Yekaterinburg, Russian Federation), D. Vakhrusheva (Yekaterinburg, Russian Federation), L. Golubeva (Yekaterinburg, Russian Federation), L. Lavrechuk (Yekaterinburg, Russian Federation)
Nontuberculous mycobacterial co-infection in HIV-negative patients with pulmonary tuberculosis I. Stepanyan (Moscow, Russian Federation), A. Zaytseva (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), E. Larionova (Moscow, Russian Federation), T. Smirnova (Moscow, Russian Federation), S. Andreevskaya (Moscow, Russian Federation), L. Chernousova (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
Cure rates in nontuberculous mycobacterial pulmonary disease M. Jankovic Makek (Zagreb, Croatia), G. Glodic (Zagreb, Croatia), I. Sabol (Zagreb, Croatia), L. Zmak (Zagreb, Croatia), A. Sola (Zagreb, Croatia), A. Marusic (Zagreb, Croatia), I. Marekovic (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), F. Dzubur (Zagreb, Croatia), M. Jakopovic (Zagreb, Croatia), B. Ticac (Rijeka, Croatia), L. Kardum Bulat (Rijeka, Croatia), S. Popovic Grle (Zagreb, Croatia), B. Barisic (Zagreb, Croatia), V. Carevic Vladic (Dubrovnik, Croatia), D. Strelec (Klenovnik, Croatia), G. Pavlisa (Zagreb, Croatia), M. Samarzija (Zagreb, Croatia)
Pleural tuberculosis: diagnostic approach A. Ben Tkhayat (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), H. Rejeb (Ariana, Tunisia), H. Kammoun (Ariana, Tunisia), I. Akrout (Ariana, Tunisia), D. Greb (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), H. Hassen (Ariana, Tunisia), L. Fekih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia)
Spontaneous pneumothorax secondary to tuberculosis: a retrospective study of 81 patients K. Higa (Tokyo, Japan), R. Sato (Tokyo, Japan), K. Takeda (Tokyo, Japan), K. Watanabe (Tokyo, Japan), M. Ikeda (Tokyo, Japan), M. Suzukawa (Tokyo, Japan), M. Kawashima (Tokyo, Japan), N. Ohshima (Tokyo, Japan), A. Yamane (Tokyo, Japan), A. Tamura (Tokyo, Japan), H. Nagai (Tokyo, Japan), H. Matsui (Tokyo, Japan), S. Tohma (Tokyo, Japan)